Efficacy and Safety of Ribociclib Combined With AI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in ER Medium to Low Expression/HER2-negative Advanced Breast Cancer: a Phase II Randomised Controlled Clinical Study
Latest Information Update: 28 Oct 2024
At a glance
- Drugs Anastrozole (Primary) ; Exemestane (Primary) ; Goserelin (Primary) ; Letrozole (Primary) ; Ribociclib (Primary) ; Capecitabine; Docetaxel; Paclitaxel
- Indications Advanced breast cancer; HER2 negative breast cancer
- Focus Therapeutic Use
- 28 Oct 2024 New trial record